Cardiopulmonary Stress Testing Systems Market, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Published on : Apr-2020 | List of Tables : 22 | List of Figures : 97 | No. of Pages : 170 | Report Code : FACT4693MR | Format :

Increasing Awareness about Accurate CVD Assessment amid COVID-19 Pandemic to Heighten Growth Prospects

Cardiovascular Disease (CVD) remains one of the leading causes of death across the world. The condition is responsible for 17.1 million deaths globally in 2015. Out of these, around three-quarters of the deaths occurred in low to middle income countries. Limited access to monitoring and diagnosis of CVDs is attributed as a major reason for the increasing death rate. This problem is further being compounded by the COVID-19 pandemic which has gripped the globe

Fortunately, various national and regional governments, in collaboration with international non-profit organizations, have initiated numerous awareness campaigns to enlighten people about accurate assessment of CVDs amidst this global crisis. In addition, increased budgetary allocation and provision of affordable treatment to patients are burgeoning. This has encouraged market players to establish their businesses in prospective markets and introduce technologically enhanced testing systems.

The recent COVID-19 pandemic has generated potential threats to cardiac patients. The virus is capable of severely damaging cardiac tissues by inflaming them. Realizing this, hospitals and clinics have ramped up their efforts in providing top quality medical care and reduce complications among existing patients.

Riding on the back of the aforementioned trends, the global cardiopulmonary stress testing devices market is poised to expand positively at a CAGR of 4.8% during the forecast period (2020-2025). A growing geriatric population pool with CVDs and critically ill COVID-19 patients is also anticipated to boost the global cardiopulmonary testing services market.

Cardiopulmonary Exercise Testing Systems (CPET) to Dominate, Stress ECG to Catch Up

The cardiopulmonary exercise testing systems (CPET) segment is anticipated to capture the lion’s share of the global cardiopulmonary stress testing systems market. This is attributed to the growing demand for novel testing systems among critically ill COVID-19 patients. Moreover, the CPET provides a distinct and complimentary assessment by facilitating a more precise and reliable measurement of a patient’s functional capacity. It provides better validation for evaluating the prognosis of heart failure patients and measuring responses to heart failure therapy. The CPET segment is poised to capture more than half of the global cardiopulmonary stress testing services market, expanding 1.3x during the forecast period.

global cardiopulmonary stress testing systems market 01

To know more about the cardiopulmonary stress testing market, ask an analyst here

The stress EGC segment is anticipated to be the second-most lucrative market. A burgeoning pool of cardiovascular patients in developing countries, low cost product offerings in high patient population countries and strong market penetration of local manufacturers are anticipate to leverage growth prospects for the ECG devices during the forecast period. For instance, companies such as Koninklijke Philips N.V., GE Healthcare and Schiller AG have consolidated their market footprints through manufacturing of ECG devices such as the DXL 16-Lead ECG Algorithm, the CASE Exercise Testing System and the CARDIOVIT AT-180 High-performance 16-channel ECG system. The stress ECG segment is poised to expand at a CAGR of 5.0% during the forecast period.

North America Captures the Lion’s Share, Asia-Pacific to Grow at a Rapid Pace

North America is poised to capture one-third of the global cardiopulmonary stress testing market. Increasing hospitalization rates of COVID-19 patients and rising efficiency in accurate diagnostics of cardiovascular diseases are anticipated to leverage the market growth. The North American cardiopulmonary stress testing services market is projected to expand at a CAGR of 4.9% during the forecast period

global cardiopulmonary stress testing systems market 02

For critical regional insights on the cardiopulmonary stress testing systems market, request for a report sample here

Asia-Pacific is anticipated to be the most lucrative market for cardiopulmonary stress testing services. A strong presence of key manufacturers in the region and increased awareness about stress testing are major factors likely to contribute to the growth of the Asia-Pacific market. The Asia-Pacific region is poised to expand at a CAGR of 5.4%, capturing over one-fourth of the global cardiopulmonary stress testing services market during the forecast period.

Stakeholders to Innovate and Incorporate Advanced Technologies

The global cardiopulmonary stress testing services market is highly fragmented, with the top five market players comprising less than half of the total market. Schiller AG, GE Healthcare, Hill-Rom Holdings, Inc., Koninklijke Philips N.V and VYAIRE MEDICAL INC., are major market players.

Schiller AG is a pioneer in the global cardiopulmonary stress testing services market. The company has been continuously improving its product pipeline and technologies for patient assessment via stress tests. The company manufactures the CARDIOVIT AT-200 EXCELLENCE ERGOSPIRO which can perform both pulmonary function tests (PFTs) and metabolic tests with diagnostic quality-12 or 16-leade exercise ECG conveniently and accurately in a single device.

Likewise, VYAIRE MEDICAL INC., produces the Vmax and Vyntus CPX CPET devices. The latter device is equipped with a digital volume transducer (DVT) flow sensory technology which provides an accurate and reliable flow and volume measurement of cardiac functioning.

COVID-19 Market Insights:

While people of all ages are vulnerable to infection, the COVID-19 virus poses significant risks for those aged above 60 years with underlying medical conditions. These include cardiovascular disease and hypertension. A person with a pre-existing heart disease who gets infected with COVID-19 may experience a heart attack or develop congestive heart failure. In some cases, the infection can also trigger myocarditis, or inflammation of the heart muscle. While simple precautionary measures such as washing of hands regularly, cleaning and disinfecting frequently touched surfaces and social distancing may help prevent the spread of the infection, companies are investing significantly in finding a cure for the diseases through vaccinations or oral medications.

A recent significant development has occurred in the United States with respect to the COVID-19 pandemic. The FDA has relaxed regulations on the Extracorporeal Membrane Oxygenation (ECMO) devices and cardiopulmonary bypass devices to help hospitals fight the novel coronavirus disease. They have been granted clearance to use cardiopulmonary bypass devices outside their authorized indications. This development is anticipated to spur key cardiopulmonary device manufacturers to increase their production volume and provide more devices to key end-users. Companies like Medtronic and Getinge are poised to experience an uptick in their production operations. Till the time the COVID-19 persists, hospitals shall be permitted to use cardiopulmonary bypass devices in ECMO circuits beyond the six-hour time limit.

Global Cardiopulmonary Stress Testing Systems Market - Scope of the Report

The recent study by Fact.MR on global cardiopulmonary stress testing systems market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that arecurrently determining the growth of the global cardiopulmonary stress testing systems market. This reportexplicates on vital dynamics such as the drivers, restraints and opportunities for key market players along with key stakeholders and emerging players associated with the manufacturing of cardiopulmonary stress testing system devices. The study also provides dynamics that are responsible for influencing the future status of the global cardiopulmonary stress testing systems market over the forecast period.

A detailed assessment of the global cardiopulmonary stress testing systems market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the global cardiopulmonary stress testing systems market along with their product portfolio enhances the reliability of this comprehensive research study.

Global Cardiopulmonary Stress Testing Systems Market: Report Summary

The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in the global cardiopulmonary stress testing systems market across the globe.

A comprehensive estimate of the global cardiopulmonary stress testing systems market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of the global cardiopulmonary stress testing systemsdevicesduring the forecast period. Price point comparison by region with global average price is also considered in the study.

Global Cardiopulmonary Stress Testing Systems Market Segmentation

Fact.MR has studied the global cardiopulmonary stress testing systemsmarket with detailed segmentation on the basis of product, end-user and region.

Product

End-user

Region

Cardiopulmonary Exercise Testing (CPET) Systems

Hospitals

North America

Stress ECG

Specialty Clinics/Cardiology Clinics

Europe

Pulse Oximeters

Ambulatory Surgical Centers

Asia Pacific

Stress Blood Pressure Monitors

Diagnostic Centers

Latin America

Single-photon Emission Computed Tomography (SPECT)

 

Middle East & Africa (MEA)

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

Global Cardiopulmonary Stress Testing Systems Market: Analysis on Market Size Evaluation

The global cardiopulmonary stress testing systems market has been analyzed for each market segment, in terms of value (US$ Mn).

Market estimates at global and regionallevels for Cardiopulmonary stress testing systems market is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent cardiopulmonary stress testing systems market segments, along with market attractiveness evaluation has been incorporated in the report.

Global Cardiopulmonary Stress Testing Systems Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the global cardiopulmonary stress testing systems market report, which havehelped deliver projections on regional markets. These chapters include the regional macros (economic and business environment outlook), which are expected to have a momentous influence on the growth of the global cardiopulmonary stress testing systems market during the forecast period.

Country-specific valuation on demand for cardiopulmonary stress testing systemshas been offered for each regional market, along with the market scope, estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for emerging countries has also been included in the report.

Global Cardiopulmonary Stress Testing Systems Market: In-Depth Analysis on Competitive Landscape

The report sheds light on the leading manufacturers of global cardiopulmonary stress testing systems drugs market along with their detailed profiles. Essential and up-to-date data andinformation related to the market performers, who are principally engaged in the production of cardiopulmonary stress testing systems devices, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which includes essentials such as product portfolio, key strategies along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in the global cardiopulmonary stress testing systems market. Prominent manufacturers with established market presence in the global cardiopulmonary stress testing systems market areHill-Rom Holdings, Inc., Schiller AG, MGC Diagnostics Corporation, VYAIRE MEDICAL INC., NIHON KODEN CORPORATION, Masimo and Koninklijke Philips, to name a few.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cardiopulmonary Stress Testing Systems Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Key Market Indicators

    4.4. Market Dynamics

        4.4.1. Drivers

            4.4.1.1. Rising awareness among end-users about accurate assessment of cardiovascular diseases due to new monitoring technologies is significantly enhancing the diagnosis rate

            4.4.1.2. Growing geriatric population propels adoption of preventive disease-monitoring products

        4.4.2. Restraints

            4.4.2.1. Shutdown of Chalk River resulting in shortage of Tc-99 m and reduction in the number of SPECT procedures

            4.4.2.2. Implementation of legal provisions that promote cost containment/cost-cutting strategies

        4.4.3. Opportunity

    4.5. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecasts, 2020–2025

        4.5.1. Market Revenue Projections (US$ Mn)

    4.6. Porter’s Five Force Analysis

    4.7. Market Outlook

    4.8. Regulatory Scenarios

    4.9. Cardiovascular Diseases Prevalence, by Region

    4.10. Applied SWOT Analysis

5. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecasts, By Product Type 

    5.1. Introduction & Definition

    5.2. Key Findings / Developments

    5.3. Key Trends

    5.4. Market Value Forecast ByProduct Type, 2020–2025

        5.4.1. Cardiopulmonary Exercise Testing (CPET) Systems

        5.4.2. Stress ECG

        5.4.3. Pulse Oximeters

        5.4.4. Stress Blood Pressure Monitors

        5.4.5. Single-Photon Emission Computed Tomography (SPECT)

    5.5. Product Type Comparison Matrix

    5.6. Market Attractiveness By Product Type 

6. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecasts, By End-user 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Key Trends

    6.4. Market Value Forecast By End-user, 2020–2025

        6.4.1. Hospitals

        6.4.2. Specialty Clinics/Cardiology Clinics

        6.4.3. Ambulatory Surgical Centers

        6.4.4. Diagnostic Centers

    6.5. Market Attractiveness By End-user 

7. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecasts, By Region

    7.1. Key Findings

    7.2. Policies and Regulations

    7.3. Market Value Forecast By Region

        7.3.1. North America 

        7.3.2. Europe 

        7.3.3. Asia Pacific 

        7.3.4. Latin America 

        7.3.5. Middle East and Africa 

    7.4. Market Attractiveness By Country/Region

8. North America Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

    8.1. Introduction

        8.1.1. Key Findings

        8.1.2. Key Trends

    8.2. Market Value Forecast By Product Type, 2020–2025

        8.2.1. Cardiopulmonary Exercise Testing (CPET) Systems

        8.2.2. Stress ECG

        8.2.3. Pulse Oximeters

        8.2.4. Stress Blood Pressure Monitors

        8.2.5. Single-Photon Emission Computed Tomography (SPECT)

    8.3. Market Value Forecast By End-user, 2020–2025

        8.3.1. Hospitals

        8.3.2. Specialty Clinics/Cardiology Clinics

        8.3.3. Ambulatory Surgical Centers

        8.3.4. Diagnostic Centers

    8.4. Market Value Forecast By Country, 2020–2025

        8.4.1. U.S.

        8.4.2. Canada

    8.5. Market Attractiveness Analysis 

        8.5.1. By Product Type 

        8.5.2. By End-user 

        8.5.3. By Country

9. Europe Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

        9.1.2. Key Trends

    9.2. Market Value Forecast ByProduct Type, 2020–2025

        9.2.1. Cardiopulmonary Exercise Testing (CPET) Systems

        9.2.2. Stress ECG

        9.2.3. Pulse Oximeters

        9.2.4. Stress Blood Pressure Monitors

        9.2.5. Single-Photon Emission Computed Tomography (SPECT)

    9.3. Market Value Forecast By End-user, 2020–2025

        9.3.1. Hospitals

        9.3.2. Specialty Clinics/Cardiology Clinics

        9.3.3. Ambulatory Surgical Centers

        9.3.4. Diagnostic Centers

    9.4. Market Value Forecast By Country/Sub-region, 2020–2025

        9.4.1. U.K.

        9.4.2. Germany

        9.4.3. France

        9.4.4. Italy

        9.4.5. Spain

        9.4.6. Russia

        9.4.7. Rest of Europe

    9.5. Market Attractiveness Analysis 

        9.5.1. By Product Type 

        9.5.2. By End-user 

        9.5.3. By Country/Sub-region

10. Asia Pacific Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

        10.1.2. Key Trends

    10.2. Market Value Forecast By Product Type, 2020–2025

        10.2.1. Cardiopulmonary Exercise Testing (CPET) Systems

        10.2.2. Stress ECG

        10.2.3. Pulse Oximeters

        10.2.4. Stress Blood Pressure Monitors

        10.2.5. Single-Photon Emission Computed Tomography (SPECT)

    10.3. Market Value Forecast By End-user, 2020–2025

        10.3.1. Hospitals

        10.3.2. Specialty Clinics/Cardiology Clinics

        10.3.3. Ambulatory Surgical Centers

        10.3.4. Diagnostic Centers

    10.4. Market Value Forecast By Country/Sub-region, 2020–2025

        10.4.1. India

        10.4.2. China

        10.4.3. Japan

        10.4.4. Australia & New Zealand

        10.4.5. Rest of Asia Pacific

    10.5. Market Attractiveness Analysis 

        10.5.1. By Product Type 

        10.5.2. By End-user 

        10.5.3. By Country/Sub-region

11. Latin America Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

        11.1.2. Key Trends

    11.2. Market Value Forecast By Product Type, 2020–2025

        11.2.1. Cardiopulmonary Exercise Testing (CPET) Systems

        11.2.2. Stress ECG

        11.2.3. Pulse Oximeters

        11.2.4. Stress Blood Pressure Monitors

        11.2.5. Single-Photon Emission Computed Tomography (SPECT)

    11.3. Market Value Forecast By End-user, 2020–2025

        11.3.1. Hospitals

        11.3.2. Specialty Clinics/Cardiology Clinics

        11.3.3. Ambulatory Surgical Centers

        11.3.4. Diagnostic Centers

    11.4. Market Value Forecast By Country/Sub-region, 2020–2025

        11.4.1. Brazil

        11.4.2. Mexico

        11.4.3. Rest of Latin America

    11.5. Market Attractiveness Analysis 

        11.5.1. By Product Type 

        11.5.2. By End-user 

        11.5.3. By Country/Sub-region

12. Middle East and Africa Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

        12.1.2. Key Trends

    12.2. Market Value Forecast By Product Type, 2020–2025

        12.2.1. Cardiopulmonary Exercise Testing (CPET) Systems

        12.2.2. Stress ECG

        12.2.3. Pulse Oximeters

        12.2.4. Stress Blood Pressure Monitors

        12.2.5. Single-Photon Emission Computed Tomography (SPECT)

    12.3. Market Value Forecast By End-user, 2020–2025

        12.3.1. Hospitals

        12.3.2. Specialty Clinics/Cardiology Clinics

        12.3.3. Ambulatory Surgical Centers

        12.3.4. Diagnostic Centers

    12.4. Market Value Forecast By Country/Sub-region, 2020–2025

        12.4.1. South Africa

        12.4.2. GCC Countries

        12.4.3. Israel

        12.4.4. Rest of Middle East and Africa

    12.5. Market Attractiveness Analysis 

        12.5.1. By Product Type 

        12.5.2. By End-user 

        12.5.3. By Country/Sub-region

13. Competition Landscape

    13.1. Market Player – Competition Matrix (By Tier and Size of companies)

    13.2. Market Share Analysis By Company (2018)

    13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

        13.3.1. Koninklijke Philips N.V.

            13.3.1.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.1.2. Financial Overview

            13.3.1.3. SWOT Analysis

            13.3.1.4. Strategic Overview

        13.3.2. Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.) 

            13.3.2.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.2.2. Financial Overview

            13.3.2.3. Product Portfolio

            13.3.2.4. SWOT Analysis

            13.3.2.5. Strategic Overview

        13.3.3. General Electric Company (GE Healthcare)

            13.3.3.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.3.2. Financial Overview

            13.3.3.3. Product Portfolio

            13.3.3.4. SWOT Analysis

            13.3.3.5. Strategic Overview

        13.3.4. MGC Diagnostics Corporation 

            13.3.4.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.4.2. Financial Overview

            13.3.4.3. Product Portfolio

            13.3.4.4. SWOT Analysis

            13.3.4.5. Strategic Overview

        13.3.5. OSI Systems, Inc. (Spacelabs Healthcare)

            13.3.5.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.5.2. Financial Overview

            13.3.5.3. Product Portfolio.

            13.3.5.4. SWOT Analysis

            13.3.5.5. Strategic Overview

        13.3.6. Masimo 

            13.3.6.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.6.2. Financial Overview

            13.3.6.3. Product Portfolio

            13.3.6.4. SWOT Analysis

            13.3.6.5. Strategic Overview

        13.3.7. NIHON KOHDEN CORPORATION 

            13.3.7.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.7.2. Financial Overview

            13.3.7.3. Product Portfolio

            13.3.7.4. SWOT Analysis

            13.3.7.5. Strategic Overview

        13.3.8. COSMED 

            13.3.8.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.8.2. Financial Overview

            13.3.8.3. Product Portfolio

            13.3.8.4. SWOT Analysis

            13.3.8.5. Strategic Overview 

        13.3.9. Halma plc (SunTech Medical, Inc.) 

            13.3.9.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.9.2. Financial Overview

            13.3.9.3. Product Portfolio

            13.3.9.4. SWOT Analysis

            13.3.9.5. Strategic Overview

        13.3.10. Schiller AG 

            13.3.10.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.10.2. Financial Overview

            13.3.10.3. Product Portfolio

            13.3.10.4. SWOT Analysis

            13.3.10.5. Strategic Overview

        13.3.11. Vyaire Medical, Inc. 

            13.3.11.1. Company Overview (HQ, Business Segments, Employee Strengths)

            13.3.11.2. Financial Overview

            13.3.11.3. Product Portfolio

            13.3.11.4. SWOT Analysis

            13.3.11.5. Strategic Overview

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Cardiopulmonary Stress Testing Systems Market, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025